세계의 제네릭 의약품 시장 규모 조사 및 예측 : 유형별, 용도별, 제품별, 투여 경로별, 유통 채널별, 지역별 분석(2023-2030년)

Global Generic Pharmaceuticals Market is valued at approximately USD 361.7 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2029. Generic pharmaceuticals are medications that are identical, or bioequivalent, to brand-name drugs in terms of dosage, safety, strength, route of administration, quality, and intended use. Generic drugs are produced after the patent for the original brand-name drug has expired. This allows other pharmaceutical companies to manufacture and sell the same medication at a lower cost because they do not need to invest in the costly research and development that is required to create a new drug. The Generic Pharmaceuticals market is expanding because of factors such as rising, increasing ANDA approval and generic product launches and government initiatives to promote the usage of generics.

The rise in the number of ANDA approvals and generic medication product launches accounts for the market growth. according to the U.S. FDA's Generic Drugs Annual report, the number of ANDA approvals increased from 948 in 2020 to 776 in 2021. Additionally, from the same source, it was reported that 100 ANDAs had been approved overall by the end of 2021. Governments have implemented programs that offer various opportunities for significant generic drug players to cut back on expenditure on pharmaceuticals. As an illustration, by using generic medications in 2021, the U.S. government saved USD 373 million on pharmaceutical costs. According to the AAM Generic Drug & Biosimilars Access & Savings Report 2021, 91% of prescriptions are filled with generic medication, which represents 18.2% of prescription drug costs. In addition, the increasing Disease Burden and Rising Geriatric Population are creating lucrative growth in the market. However, a lack of transparency about the actual price of generic drugs hampers the market growth.

The key regions considered for the Global Generic Pharmaceuticals Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of key market growth and the region's increasing disease prevalence, along with these increasing number of favorable government initiatives coupled with the rising number of product launches and demand for a generic drug is driving the market growth in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• LUPIN
• AbbVie Inc. (Allergan)
• AstraZeneca
• Sawai Pharmaceutical Co., Ltd.
• Hikma Pharmaceuticals PLC
• Dr. Reddy's Laboratories Ltd.

Recent Developments in the Market:

• In January 2022, the Mark Cuban Cost Plus Drugs Company (MCCPDC) announced the launch of an online pharmacy. The pharmacy would offer around more than 100 generic drugs at a low cost to patients.

Global Generic Pharmaceuticals Market Report Scope:

• Historical Data: - 2020 - 2021
• Base Year for Estimation: - 2022
• Forecast period: - 2023-2030
• Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: - Type, Application, Product, Application, Route of Administration, Distribution Channel, Region
• Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

• Simple Generics
• Specialty Generics
• Biosimilars

By Application:

• Central Nervous System Disorders
• Respiratory Diseases
• Hormones & Related Diseases
• Gastrointestinal Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Others

By Product:

• Small Molecule
• Large Molecule

By Route of Administration:

• Oral
• Injectable
• Inhalable
• Others

Distribution Channel:

• Online Pharmacies
• Hospitals Pharmacies
• Retail Pharmacies

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Generic Pharmaceuticals Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Generic Pharmaceuticals Market, by Type, 2020-2030 (USD Billion)
  • 1.2.3. Generic Pharmaceuticals Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4. Generic Pharmaceuticals Market, by Product, 2020-2030 (USD Billion)
  • 1.2.5. Generic Pharmaceuticals Market, by Route of Administration, 2020-2030 (USD Billion)
  • 1.2.6. Generic Pharmaceuticals Market, by Distribution Channel, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Generic Pharmaceuticals Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Generic Pharmaceuticals Market Dynamics

• 3.1. Generic Pharmaceuticals Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing ANDA approval and Generic Product Launches
    • 3.1.1.2. Government initiatives to promote usage of generics
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Generic Pharmaceuticals
    • 3.1.2.2. Pricing issues
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing Disease Burden
    • 3.1.3.2. Rising Geriatric Population

Chapter 4. Global Generic Pharmaceuticals Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Generic Pharmaceuticals Market, by Type

• 5.1. Market Snapshot
• 5.2. Global Generic Pharmaceuticals Market by Type, Performance - Potential Analysis
• 5.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 5.4. Generic Pharmaceuticals Market, Sub Segment Analysis
  • 5.4.1. Simple Generics
  • 5.4.2. Specialty Generics
  • 5.4.3. Biosimilars

Chapter 6. Global Generic Pharmaceuticals Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Generic Pharmaceuticals Market by Application, Performance - Potential Analysis
• 6.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Generic Pharmaceuticals Market, Sub Segment Analysis
  • 6.4.1. Central Nervous System Disorders
  • 6.4.2. Respiratory Diseases
  • 6.4.3. Hormones & Related Diseases
  • 6.4.4. Gastrointestinal Diseases
  • 6.4.5. Cardiovascular Diseases
  • 6.4.6. Infectious Diseases
  • 6.4.7. Others

Chapter 7. Global Generic Pharmaceuticals Market, by Product

• 7.1. Market Snapshot
• 7.2. Global Generic Pharmaceuticals Market by Product, Performance - Potential Analysis
• 7.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 7.4. Generic Pharmaceuticals Market, Sub Segment Analysis
  • 7.4.1. Small Molecule
  • 7.4.2. Large Molecule

Chapter 8. Global Generic Pharmaceuticals Market, by Route of Administration

• 8.1. Market Snapshot
• 8.2. Global Generic Pharmaceuticals Market by Route of Administration, Performance - Potential Analysis
• 8.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
• 8.4. Generic Pharmaceuticals Market, Sub Segment Analysis
  • 8.4.1. Oral
  • 8.4.2. Injectable
  • 8.4.3. Inhalable
  • 8.4.4. Others

Chapter 9. Global Generic Pharmaceuticals Market, by Distribution Channel

• 9.1. Market Snapshot
• 9.2. Global Generic Pharmaceuticals Market by Distribution Channel, Performance - Potential Analysis
• 9.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2020-2030 (USD Billion)
• 9.4. Generic Pharmaceuticals Market, Sub Segment Analysis
  • 9.4.1. Online Pharmacies
  • 9.4.2. Retail Pharmacies
  • 9.4.3. Hospital Pharmacies

Chapter 10. Global Generic Pharmaceuticals Market, Regional Analysis

• 10.1. Top Leading Countries
• 10.2. Top Emerging Countries
• 10.3. Generic Pharmaceuticals Market, Regional Market Snapshot
• 10.4. North America Generic Pharmaceuticals Market
  • 10.4.1. U.S. Generic Pharmaceuticals Market
    • 10.4.1.1. Type breakdown estimates & forecasts, 2020-2030
    • 10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 10.4.1.3. Product breakdown estimates & forecasts, 2020-2030
    • 10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030 10.4.1.5. Distribution Channel breakdown estimates & forecasts, 2020-2030
  • 10.4.2. Canada Generic Pharmaceuticals Market
• 10.5. Europe Generic Pharmaceuticals Market Snapshot
  • 10.5.1. U.K. Generic Pharmaceuticals Market
  • 10.5.2. Germany Generic Pharmaceuticals Market
  • 10.5.3. France Generic Pharmaceuticals Market
  • 10.5.4. Spain Generic Pharmaceuticals Market
  • 10.5.5. Italy Generic Pharmaceuticals Market
  • 10.5.6. Rest of Europe Generic Pharmaceuticals Market
• 10.6. Asia-Pacific Generic Pharmaceuticals Market Snapshot
  • 10.6.1. China Generic Pharmaceuticals Market
  • 10.6.2. India Generic Pharmaceuticals Market
  • 10.6.3. Japan Generic Pharmaceuticals Market
  • 10.6.4. Australia Generic Pharmaceuticals Market
  • 10.6.5. South Korea Generic Pharmaceuticals Market
  • 10.6.6. Rest of Asia Pacific Generic Pharmaceuticals Market
• 10.7. Latin America Generic Pharmaceuticals Market Snapshot
  • 10.7.1. Brazil Generic Pharmaceuticals Market
  • 10.7.2. Mexico Generic Pharmaceuticals Market
• 10.8. Rest of The World Generic Pharmaceuticals Market

Chapter 11. Competitive Intelligence

• 11.1. Key Company SWOT Analysis
  • 11.1.1. Company 1
  • 11.1.2. Company 2
  • 11.1.3. Company 3
• 11.2. Top Market Strategies
• 11.3. Company Profiles
  • 11.3.1. Teva Pharmaceutical Industries Ltd.
    • 11.3.1.1. Key Information
    • 11.3.1.2. Overview
    • 11.3.1.3. Financial (Subject to Data Availability)
    • 11.3.1.4. Product Summary
    • 11.3.1.5. Recent Developments
  • 11.3.2. Viatris Inc.
  • 11.3.3. Novartis AG
  • 11.3.4. Sun Pharmaceutical Industries Ltd.
  • 11.3.5. LUPIN
  • 11.3.6. AbbVie Inc. (Allergan)
  • 11.3.7. AstraZeneca
  • 11.3.8. Sawai Pharmaceutical Co., Ltd.
  • 11.3.9. Hikma Pharmaceuticals PLC
  • 11.3.10. Dr. Reddy's Laboratories Ltd.

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes
• 12.3. Research Assumption